肿瘤学临床试验主要研究者中的女性代表情况。
Women's Representation Among Lead Investigators of Clinical Trials in Oncology.
作者信息
Ludmir Ethan B, Mainwaring Walker, Miller Austin B, Lin Timothy A, Jethanandani Amit, Espinoza Andres F, Holliday Emma B
机构信息
The University of Texas MD Anderson Cancer Center, Houston.
Baylor College of Medicine, Houston, Texas.
出版信息
JAMA Oncol. 2019 Oct 1;5(10):1501-1502. doi: 10.1001/jamaoncol.2019.2196.
Abstract
This database study assesses the number of female lead investigators of randomized clinical trials registered in ClinicalTrials.gov.
摘要
这项数据库研究评估了在ClinicalTrials.gov上注册的随机临床试验中女性首席研究员的数量。
相似文献
1
Women's Representation Among Lead Investigators of Clinical Trials in Oncology.肿瘤学临床试验主要研究者中的女性代表情况。
JAMA Oncol. 2019 Oct 1;5(10):1501-1502. doi: 10.1001/jamaoncol.2019.2196.
2
Year of the Woman, Decade of the Man: trajectories of growth in women's state legislative representation.女性之年，男性之十年：女性在州立法机构代表权的增长轨迹
Soc Sci Res. 2009 Mar;38(1):86-102. doi: 10.1016/j.ssresearch.2008.08.003.
3
Recruitment of women research participants: the Women's Health Registry at the University of Michigan.招募女性研究参与者：密歇根大学的女性健康登记处。
J Womens Health (Larchmt). 2007 Jun;16(5):721-8. doi: 10.1089/jwh.2006.0242.
4
Examining structured representation and designated fiscal support for women's health in the U.S. Department of Health and Human Resources.审视美国卫生与公众服务部对女性健康的结构化表述及指定财政支持。
J Womens Health Gend Based Med. 2001 Nov;10(9):849-60. doi: 10.1089/152460901753285741.
5
Women's Representation in Leadership Positions in Academic Medical Oncology, Radiation Oncology, and Surgical Oncology Programs.女性在学术肿瘤学、放射肿瘤学和外科肿瘤学项目中的领导职位中的代表性。
JAMA Netw Open. 2020 Mar 2;3(3):e200708. doi: 10.1001/jamanetworkopen.2020.0708.
6
Women's health and nutrition research: US governmental concerns.女性健康与营养研究：美国政府关切的问题。
J Am Coll Nutr. 1993 Aug;12(4):329-36. doi: 10.1080/07315724.1993.10718318.
7
Women and contraception in research: a pilot study.研究中的女性与避孕：一项试点研究。
J Womens Health (Larchmt). 2009 Apr;18(4):507-12. doi: 10.1089/jwh.2008.0899.
8
Representation of women in randomized clinical trials of cardiovascular disease prevention.心血管疾病预防随机临床试验中的女性代表性。
Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):135-42. doi: 10.1161/CIRCOUTCOMES.110.868307. Epub 2010 Feb 16.
9
Evaluating the Representation and Responsiveness of the United Nations Commission on the Status of Women (CSW) to Diverse Women Populations Worldwide.评估联合国妇女地位委员会（CSW）对全球不同女性群体的代表性和响应能力。
Front Sociol. 2019 Jul 9;4:41. doi: 10.3389/fsoc.2019.00041. eCollection 2019.
10
Economic Benefits of Investing in Women's Health: A Systematic Review.投资女性健康的经济效益：一项系统综述。
PLoS One. 2016 Mar 30;11(3):e0150120. doi: 10.1371/journal.pone.0150120. eCollection 2016.
引用本文的文献
1
Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally.以患者为中心的结局的全球视角：在全球推进以患者为中心的癌症临床试验。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):35-41. doi: 10.1093/jncimonographs/lgae043.
2
A 20-year analysis of gender trends in oncology authorship in the Cochrane database of systematic reviews.对Cochrane系统评价数据库中肿瘤学领域作者署名性别趋势的20年分析。
Front Oncol. 2024 Oct 15;14:1450475. doi: 10.3389/fonc.2024.1450475. eCollection 2024.
3
Navigating the challenges of clinical trial professionals in the healthcare sector.应对医疗保健领域临床试验专业人员面临的挑战。
Front Med (Lausanne). 2024 Jun 3;11:1400585. doi: 10.3389/fmed.2024.1400585. eCollection 2024.
4
Promoting Women and Historically Excluded Minorities in Medicine as Essential Leaders of Research.促进女性及历史上受排斥的少数群体成为医学研究的重要领导者。
Adv Radiat Oncol. 2023 Jun 17;8(6):101301. doi: 10.1016/j.adro.2023.101301. eCollection 2023 Nov-Dec.
5
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research.当代 III 期临床癌症研究中局部治疗试验的流行率、趋势和特征。
Cancer. 2023 Nov 1;129(21):3430-3438. doi: 10.1002/cncr.34929. Epub 2023 Jun 29.
6
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership.发生地之所在：国家临床试验网络临床试验领导力中的多样性、公平性和包容性问题。
J Natl Cancer Inst. 2023 Oct 9;115(10):1132-1138. doi: 10.1093/jnci/djad121.
7
What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature.在胆管癌（BTC）的后期系统性临床试验中，作者的性别构成如何？——对已发表文献的回顾性分析。
BMJ Open. 2022 Oct 26;12(10):e064954. doi: 10.1136/bmjopen-2022-064954.
8
Gender disparities in multiple myeloma publications.多发性骨髓瘤出版物中的性别差异。
EJHaem. 2022 Jun 15;3(3):966-969. doi: 10.1002/jha2.470. eCollection 2022 Aug.
9
Gender profile of principal investigators in a large academic clinical trials group.一个大型学术临床试验团队中主要研究者的性别概况。
Front Surg. 2022 Jul 18;9:962120. doi: 10.3389/fsurg.2022.962120. eCollection 2022.
10
Underrepresentation and undertreatment of women in hematology: An unsolved issue.血液学领域中女性患者的代表性不足和治疗不足：一个尚未解决的问题。
Res Pract Thromb Haemost. 2022 Jul 21;6(5):e12767. doi: 10.1002/rth2.12767. eCollection 2022 Jul.
Zotero 插件